The hospitalist perspective on treatment of community-acquired bacterial pneumonia

Amin, Alpesh N., Cerceo, Elizabeth A., Deitelzweig, Steven B., Pile, James C., Rosenberg, David J. and Sherman, Bradley M. (2014) The hospitalist perspective on treatment of community-acquired bacterial pneumonia. Postgraduate Medicine, 126 2: 18-29. doi:10.3810/pgm.2014.03.2737


Author Amin, Alpesh N.
Cerceo, Elizabeth A.
Deitelzweig, Steven B.
Pile, James C.
Rosenberg, David J.
Sherman, Bradley M.
Title The hospitalist perspective on treatment of community-acquired bacterial pneumonia
Journal name Postgraduate Medicine   Check publisher's open access policy
ISSN 1941-9260
0032-5481
Publication date 2014-01-01
Year available 2014
Sub-type Article (original research)
DOI 10.3810/pgm.2014.03.2737
Open Access Status Not yet assessed
Volume 126
Issue 2
Start page 18
End page 29
Total pages 12
Place of publication Philadelphia, PA, United States
Publisher Taylor & Francis
Language eng
Formatted abstract
Community-acquired bacterial pneumonia (CABP) is an important health care concern in the United States and worldwide, and is associated with significant morbidity, mortality, and health care expenditure. Streptococcus pneumoniae is the most frequent causative pathogen of CABP. Other common pathogens include Staphylococcus aureus, Haemophilus influenzae, Enterobacteriaceae, Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae. However, in clinical practice, the causative pathogen of CABP is most often not identified. Therefore, a common treatment approach for patients hospitalized with CABP is empiric antibiotic therapy with a β-lactam in combination with a macrolide, respiratory fluoroquinolones, or tetracyclines. An increase in the incidence of S. pneumoniae that is resistant to frequently used antibiotics, including β-lactams, macrolides, and tetracyclines, provides a challenge for the physician when selecting empiric antimicrobial therapy. When patients with CABP do not respond to initial therapy, they must be adequately reevaluated with further diagnostic testing, change in antimicrobial regimen, and/or transfer of the patient to a higher level of care. The role of hospital medicine physicians is crucial in treating patients who are hospitalized with CABP. An important focus of hospitalists is to provide care improvement in a way that addresses both patient and hospital needs. It is essential that the hospitalist provides best possible patient care, including adherence to quality measures, optimizing the patient’s hospital length of stay, and arranging adequate post-discharge care in an effort to prevent readmission and provide appropriate ongoing outpatient care.
Keyword Antimicrobial therapy
Community-acquired pneumonia
Hospital medicine
Hospitalist
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 4 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 4 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 05 Aug 2016, 19:46:46 EST by System User on behalf of Learning and Research Services (UQ Library)